Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia.

Skavland J, Jørgensen KM, Hadziavdic K, Hovland R, Jonassen I, Bruserud O, Gjertsen BT.

Blood Cancer J. 2011 Feb;1(2):e4. doi: 10.1038/bcj.2011.2. Epub 2011 Feb 11.

3.
4.

In vivo biological effects of ATRA in the treatment of AML.

Ryningen A, Stapnes C, Paulsen K, Lassalle P, Gjertsen BT, Bruserud O.

Expert Opin Investig Drugs. 2008 Nov;17(11):1623-33. doi: 10.1517/13543784.17.11.1623 .

PMID:
18922099
7.

The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.

Trus MR, Yang L, Suarez Saiz F, Bordeleau L, Jurisica I, Minden MD.

Leukemia. 2005 Jul;19(7):1161-8.

PMID:
15902297
8.

[Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].

Meng YS, Ma XX, Meng XQ, Wei R, Liu W, Ai GW, Zhang YX.

Zhonghua Yi Xue Za Zhi. 2007 Dec 25;87(48):3406-10. Chinese.

PMID:
18476539
9.

Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).

Rosen DB, Minden MD, Kornblau SM, Cohen A, Gayko U, Putta S, Woronicz J, Evensen E, Fantl WJ, Cesano A.

PLoS One. 2010 Oct 27;5(10):e13543. doi: 10.1371/journal.pone.0013543.

11.

Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A.

Uchino Y, Iriyama N, Hatta Y, Takei M.

Cancer Cell Int. 2015 Mar 12;15:30. doi: 10.1186/s12935-015-0176-2. eCollection 2015.

12.

Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.

Schenk T, Chen WC, Göllner S, Howell L, Jin L, Hebestreit K, Klein HU, Popescu AC, Burnett A, Mills K, Casero RA Jr, Marton L, Woster P, Minden MD, Dugas M, Wang JC, Dick JE, Müller-Tidow C, Petrie K, Zelent A.

Nat Med. 2012 Mar 11;18(4):605-11. doi: 10.1038/nm.2661.

13.

Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.

Marvin J, Swaminathan S, Kraker G, Chadburn A, Jacobberger J, Goolsby C.

Blood. 2011 Apr 14;117(15):e120-30. doi: 10.1182/blood-2010-10-316026. Epub 2011 Jan 13.

14.
18.

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.

Bug G, Ritter M, Wassmann B, Schoch C, Heinzel T, Schwarz K, Romanski A, Kramer OH, Kampfmann M, Hoelzer D, Neubauer A, Ruthardt M, Ottmann OG.

Cancer. 2005 Dec 15;104(12):2717-25.

20.

Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.

Imaizumi M, Sato A, Koizumi Y, Inoue S, Suzuki H, Suwabe N, Yoshinari M, Ichinohasama R, Endo K, Sawai T, et al.

Leukemia. 1994 Aug;8(8):1301-8.

PMID:
7520101

Supplemental Content

Support Center